Skip to content

Inovio Pharmaceuticals

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2020

    Shareholder lawsuit concerning COVID-19 vaccine claims

    Shareholders sued Inovio in August 2020, alleging that the company exaggerated evidence concerning the efficacy of its coronavirus vaccine candidate to support its stock price. The reference material reports the lawsuit but does not establish the allegations as proven.